3658 results for «2013»

Filter By

3658 results

Intracoronary imaging for complex PCI: a must!

21 May 2025 – From EuroPCR 2025

Recognize the indispensable role of intracoronary imaging in managing complex PCI cases. This session explores the evolution of multivessel NSTEMI treatment using DES, BRS, DCB, and imaging, challenges with recurrent in-stent restenosis across multiple stent layers, innovative imaging solutions for complex lesions, and diagnostic approaches to...

Intracoronary imaging for complex PCI: a must!

Management of stent-related complications

21 May 2025 – From EuroPCR 2025

This session addresses the management of stent-related complications through a series of dramatic clinical cases. Learn methodical approaches to routine and crisis scenarios including primary PCI complications, failure to stent, and unexpected challenges encountered during interventions, highlighting practical bailout techniques and decision-making frameworks.

Management of stent-related complications

TAV-in-TAV complications

21 May 2025 – From EuroPCR 2025

Focus on the complexities and challenges of TAV-in-TAV procedures in this session. Topics include planning valve-in-valve TAVI for aortic bioprosthetic valve regurgitation, managing anatomical challenges such as left ventricular outflow tract calcium and large annulus, and addressing severe bicuspid valve stenosis with impaired ventricular function. The...

TAV-in-TAV complications

Iatrogenic causes for shock treated with LV support

21 May 2025 – From EuroPCR 2025

Explore the management of iatrogenic causes of cardiogenic shock requiring left ventricular support. This session presents complex cases including shock following Bentall procedures, complications during anesthesia induction in bypass surgery, and strategic approaches to prevent and manage these critical scenarios using LV support devices.

Iatrogenic causes for shock treated with LV support

Major Late-Breaking Trials from EuroPCR 2025

21 May 2025 – From EuroPCR 2025

Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...

Major Late-Breaking Trials from EuroPCR 2025

Treatment dilemmas in STEMI patients with multivessel disease

21 May 2025 – From EuroPCR 2025

Address treatment dilemmas in STEMI patients with multivessel disease through this session focused on imaging and physiology-guided revascularisation strategies. Learn optimal approaches for cases with CABG indications, and timing considerations for non-culprit vessel revascularisation during hospital admission or later stages, supported by illustrative clinical cases.

Treatment dilemmas in STEMI patients with multivessel disease

Imaging-based strategies for complication management in STEMI

21 May 2025 – From EuroPCR 2025

Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.

Imaging-based strategies for complication management in STEMI

Complication management during mitral TEER procedures

21 May 2025 – From EuroPCR 2025

Explore complex case scenarios of complication management during mitral TEER procedures. This session covers haemodynamic challenges, thrombotic events, device malfunctions, and rare embolisation incidents, providing practical insights into effective bailout techniques and procedural problem-solving.

Complication management during mitral TEER procedures

Stent technologies, last evidence in coronary interventions

21 May 2025 – From EuroPCR 2025

Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...

Stent technologies, last evidence in coronary interventions

TAVI for aortic regurgitation: on-label and off-label use

21 May 2025 – From EuroPCR 2025

This session reviews on-label and off-label applications of transcatheter aortic valve implantation (TAVI) for treating aortic regurgitation. Examine complex cases including TAVI in patients with aortic dissection, cardiogenic shock, and valve-in-valve interventions, highlighting innovative procedural approaches and bailout strategies.

TAVI for aortic regurgitation: on-label and off-label use

Novel devices for edge-to-edge mitral repair

21 May 2025 – From EuroPCR 2025

Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.

Novel devices for edge-to-edge mitral repair

DCB PCI: are we ready for complex de novo lesions?

21 May 2025 – From EuroPCR 2025

Evaluate the readiness of drug-coated balloon (DCB) therapy for complex de novo coronary lesions. This session reviews comparative outcomes of DCB versus drug-eluting stents (DES) across CHIP risk categories, impacts of diabetes, long-term follow-up data in calcified lesions and left main bifurcations, and treatment of in-stent...

DCB PCI: are we ready for complex de novo lesions?

Antithrombotic drugs for acute coronary syndromes in women

21 May 2025 – From EuroPCR 2025

Enhance your understanding of antithrombotic drug management in women with acute coronary syndromes (ACS). This session addresses risk stratification balancing ischemic and bleeding risks, evidence-based tailored antithrombotic and revascularisation strategies in high bleeding risk patients, and diagnostic and treatment approaches for MINOCA, with illustrative cases highlighting...

Antithrombotic drugs for acute coronary syndromes in women

Management of high-risk left main lesion

21 May 2025 – From EuroPCR 2025

Focus on managing high-risk left main coronary lesions with this session featuring complex cases such as thrombotic lesions, calcified distal left main PCI with orbital atherectomy and IVUS guidance, and advanced stenting techniques. Learn practical approaches for challenging anatomical and clinical scenarios to optimize patient outcomes.

Management of high-risk left main lesion

Did danger shock change my practice?

21 May 2025 – From EuroPCR 2025

Reflect on how contemporary management of cardiogenic shock has evolved through this session. Review collaborative strategies, challenging clinical cases involving STEMI, multivessel disease, refractory shock, spontaneous coronary artery dissection, and the critical role of intracoronary imaging in guiding interventional decisions.

Did danger shock change my practice?

Strategies in treating double CTO scenarios

21 May 2025 – From EuroPCR 2025

Navigate complex double chronic total occlusion (CTO) scenarios with this session that emphasizes thorough lesion qualification and innovative techniques. Learn strategies including management of ambiguous proximal caps, sequential vessel revascularization, and advanced tools like snaring and deflection to optimize procedural success.

Strategies in treating double CTO scenarios

Unconventional situations and complications during cardiovascular interventions

21 May 2025 – From EuroPCR 2025

Explore this session to gain expert tips and practical strategies for managing unexpected complications during cardiovascular interventions. Learn how to anticipate and avoid complications in conventional procedures and discover different approaches to tackle challenging situations in the cathlab through detailed case discussions involving PCI, TAVI, and...

Unconventional situations and complications during cardiovascular interventions

Cathlab harmony: building high-performance teams

21 May 2025 – From EuroPCR 2025

Discover strategies to build and maintain high-performance teams in the cathlab environment. This session outlines how to foster a collaborative culture, address toxic behaviors, and effectively train and integrate team members to enhance teamwork and procedural success in cardiovascular interventions.

Cathlab harmony: building high-performance teams

Interventional approaches for cardiogenic shock

21 May 2025 – From EuroPCR 2025

Gain comprehensive insights into interventional strategies for cardiogenic shock, including management of non-ischemic etiologies, innovative use of ventricular vents with ECMO, the interplay of Impella, PCI, and MitraClip, and bridging techniques using left atrial veno-arterial ECMO in severe valve disease and biventricular failure.

Interventional approaches for cardiogenic shock

DES and bioadaptator technologies in contemporary practice

21 May 2025 – From EuroPCR 2025

Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...

DES and bioadaptator technologies in contemporary practice
Didn’t find what you were looking for?